ABCC2 and cholestasis: These results suggest that cAMP and TUDC can reverse TLC‐induced cholestasis (i.e., retrieval of PM‐MRP2) by inhibiting TLC‐mediated activation of MARCKS in rat hepatocytes as well as in HuH‐NTCP cells.